Stocktoria
Nutex Health Inc. NUTX
Nutex Health Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $331.5M | $274.0M | $1.4M | $1.4M | $23,166 | $0 |
| Gross profit | $444.3M | $196.3M | $34.8M | $15.4M | $179.3M | $157.6M | $535,976 | $859,356 | -$7,315 | $0 |
| R&D expense | — | — | — | — | $285,880 | $557,257 | $768,103 | $545,223 | — | — |
| Operating income | $275.6M | $130.7M | -$31.8M | -$406.6M | $170.3M | $153.2M | -$6.9M | -$840,398 | -$5.7M | -$448,595 |
| Interest expense | — | — | $16.3M | $12.5M | $6.2M | $6.4M | $92,158 | $109,799 | $367,352 | $2,579 |
| Income tax | $64.4M | $15.0M | -$5.1M | $13.1M | $965,731 | $181,341 | $0 | $0 | — | — |
| Net income | $70.8M | $52.1M | -$45.8M | -$424.8M | $132.6M | $106.0M | -$7.1M | -$950,129 | $582,062 | -$7.4M |
| EPS (diluted) | $10.48 | $9.69 | $-10.39 | $-100.36 | $0.22 | $0.18 | — | — | — | — |
| Operating cash flow | $248.1M | $23.2M | $1.3M | $50.6M | $173.4M | $86.7M | -$4.0M | -$480,049 | -$714,623 | -$274,223 |
| Free cash flow | $245.6M | $20.8M | -$8.2M | $36.0M | $136.5M | $25.5M | -$4.1M | -$480,049 | — | — |
| Cash & equivalents | $185.6M | $40.6M | $22.0M | $34.3M | $36.1M | $26,931 | $1.1M | $119,267 | $9,449 | $10,522 |
| Inventory | $2.9M | $2.9M | $3.4M | $3.5M | $2.8M | $0 | $26,988 | $0 | — | — |
| Total assets | $918.5M | $655.3M | $398.2M | $431.8M | $394.7M | $169,857 | $6.7M | $449,428 | $3.3M | $510,835 |
| Total liabilities | $495.1M | $466.8M | $319.1M | $311.4M | $203.1M | $1.3M | $4.8M | $1.9M | $959,780 | $6.4M |
| Shareholders' equity | $423.4M | $188.5M | $79.1M | $120.3M | $191.6M | $147.4M | $50.8M | -$1.5M | -$997,224 | -$5.9M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +82.4% | +93.8% | +12.9% | -33.9% | +21.0% | +19954.5% | -0.0% | +5800.9% | — | -100.0% |
| Net income growth | +35.9% | — | — | -420.4% | +25.1% | — | — | -263.2% | — | -8968.1% |
| EPS growth | +8.2% | — | — | -45718.2% | +22.2% | — | — | — | — | — |
| Free cash flow growth | +1078.0% | — | -122.9% | -73.6% | +435.7% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.